Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Azithromycin in AECB with COPD
NCT00538148Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Primary completion
- Sep 2004
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 4 trial of telithromycin in chronic bronchitis (CB), sponsored by Sanofi. Started Nov 2002; status: completed.
02
Drugs
telithromycin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00538148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538148.